TG Therapeutics Future Growth
How is TG Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
53.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 489 | 115 | 188 | 130 | 3 |
12/31/2024 | 211 | -44 | -12 | -13 | 5 |
12/31/2023 | 72 | -148 | -134 | -101 | 8 |
9/30/2022 | 5 | -239 | -239 | -239 | N/A |
6/30/2022 | 7 | -288 | -272 | -272 | N/A |
3/31/2022 | 8 | -326 | -283 | -283 | N/A |
12/31/2021 | 7 | -348 | -296 | -296 | N/A |
9/30/2021 | 4 | -343 | -261 | -261 | N/A |
6/30/2021 | 2 | -345 | -251 | -250 | N/A |
3/31/2021 | 1 | -319 | -234 | -234 | N/A |
12/31/2020 | 0 | -279 | -215 | -215 | N/A |
9/30/2020 | 0 | -231 | -193 | -193 | N/A |
6/30/2020 | 0 | -206 | -170 | -170 | N/A |
3/31/2020 | 0 | -189 | -162 | -162 | N/A |
12/31/2019 | 0 | -173 | -133 | -133 | N/A |
9/30/2019 | 0 | -187 | -136 | -136 | N/A |
6/30/2019 | 0 | -159 | -136 | -136 | N/A |
3/31/2019 | 0 | -167 | -134 | -134 | N/A |
12/31/2018 | 0 | -173 | -129 | -129 | N/A |
9/30/2018 | 0 | -150 | -117 | -117 | N/A |
6/30/2018 | 0 | -148 | -107 | -107 | N/A |
3/31/2018 | 0 | -132 | -100 | -100 | N/A |
12/31/2017 | 0 | -118 | -94 | -94 | N/A |
9/30/2017 | 0 | -111 | -89 | -89 | N/A |
6/30/2017 | 0 | -105 | -81 | -81 | N/A |
3/31/2017 | 0 | -92 | -67 | -67 | N/A |
12/31/2016 | 0 | -78 | -62 | -62 | N/A |
9/30/2016 | 0 | -72 | -58 | -57 | N/A |
6/30/2016 | 0 | -61 | N/A | -53 | N/A |
3/31/2016 | 0 | -62 | N/A | -52 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TGTX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: TGTX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TGTX is expected to become profitable in the next 3 years.
Revenue vs Market: TGTX's revenue (53.4% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: TGTX's revenue (53.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TGTX is forecast to be unprofitable in 3 years.